Major Biotechnology R - PowerPoint PPT Presentation

1 / 27
About This Presentation
Title:

Major Biotechnology R

Description:

– PowerPoint PPT presentation

Number of Views:62
Avg rating:3.0/5.0
Slides: 28
Provided by: bina4
Category:

less

Transcript and Presenter's Notes

Title: Major Biotechnology R


1
Major Biotechnology RD Institutions and their
Programmes
  • Ts. OYUNSUREN Ph.D
  • Center for Biotechnology, Institute of
    Biology, MAS, NFP of BINASIA

2
What is Biotechnology ?
  • Biotechnology is the "science and technology of
    harnessing the natural and biological
    capabilities of plants, animals, and microbes for
    the benefit of people".
  • Biotechnology is the application of biological
    knowledge, techniques and use of living organisms
    to make a product or run a process.
  • Generally, biotechnology can be divided into
    the traditional and the new, or modern
    biotechnologies

3
Traditional Biotechnology
  • The use of biological processes or organisms for
    the production of materials and services of
    benefit to humankind.
  • Many of techniques used in traditional
    biotechnology are not new in Mongolia.
    Traditional biotechnology had been used for long
    time in nomads life for processing of dairy
    products such as making of airakh ( fermented
    horse milk), kefir, cheese and other milk
    products, for preparation of leather items, for
    improving of livestock breeds etc.
  • Traditional biotechnology techniques are still
    used widely in nomads life.

4
Modern Biotechnology
  • The scientific manipulation of living
    organisms, especially at the molecular genetics
    level, to produce new products, such as hormones,
    vaccines, monoclonal antibodies and others
  • Genetic engineering Genomics
  • Cell and tissue culture Proteomics
  • Cloning
    Bioinformatics
  • Bio-nanotechnology

5
Biotechnology Policy Documents
  • The research and development of modern
    biotechnology have started since 1986
  • 1986 -the Biotechnology was declared by the
    Mongolian Government as one of the main priority
    areas of science and technology for the National
    Economy Development
  • 1989-Complex Program of Science and Technology
    Towards the Year 2005 had emphasized the
    necessity to promote research and development on
    bioproducts
  • 1991- National Program on Biotechnology for
    1991-1995 was elaborated by the Ministry of
    Science and Education , but due to social
    economical changes faced to the country was not
    considered by the Government

6
Biotechnology Policy Documents-2
  • 1998 National Program on Biotechnology
    /Biotechnology Sub-Program/ was adopted by the
    Government
  • 2002 - National Program of Science and
    Technology Development towards the Year 2010 has
    special section for Biotechnology
  • 2002- Signed the Cartagena Protocol on Biosafety
  • Law on Biosafety ? /2005/
  • National Biotechnology Strategy ? /2005/

7
Strategic objectives of National Biotechnology
Programmes
  • To establish capacity building for the
    development of biotechnology
  • To promote and coordinate RD activities in
    Biotechnology that are focused towards meeting
    national RD objectives
  • To develop and improve RD capability

8
Strategic Directions underlying the National
Biotechnology Programme
  • Research Development
  • Human Resource Development
  • Management of Biotechnology
  • International Collaboration
  • Effective National Policy

9
  • The Biotechnology research and development
    is being conducted mainly by following
    institutions
  • Mongolian Academy of Sciences
  • - Center for Biotechnology and
  • - Division of Microbiology at the Institute
    of Biology
  • - Institute Chemistry and Chemical Technology

10
  • 2. Ministry of Health
  • - Center for Biotechnology, Institute of
    Public
  • Health
  • 3. Ministry of Food and Agriculture
  • - Institute of Animal Husbandry
  • - Institute of Veterinary
  • - Food Institute

11
Research and Production companies
  • Monenzyme Research and Production Co.
  • Biokombinat
  • Shim Co.
  • Tsagaan Zalaat Co.
  • Shine Ekhlel Co.

12
Profile of Institutes
13
(No Transcript)
14
(No Transcript)
15
Biotechnology Productions
  • Biotechnology Education, Research and Production
    Center, Public Health Institute produces
  • specific immunoglobulins, gastoglobulin,
    albumin, protein, complex of aminoacids
  • 2. Biokombinat Co. produces
  • diagnostics for animal Brucellosis
    (Rose Bengal antigen, Complement fixation test
    antigen , Milk ring test antigen, Agglutination
    test antigen, Positive serum, Negative serum,
    Brucellin), for Tuberculosis (Bovine Tuberculin,
    .Avion Tuberculin), for Salmonellosis , for
    Fowl typhoid, for Anthrax (Ascoli precipitin test
    antigen, Positive serum), for Enzootic abortion
    of ewes and Serums ( Serum antisalmonellosis,
    Serum antipasteurellosis, Serum anthrax, Serum
    antienterotoxaemia, Serum anti colibacteriosis,
    Serum anti enterobacteriosis).

16
  • 3. Monenzyme Science and Production Co.Ltd.
    produces 30 kinds of products. The main products
    include proteolytic enzymes from pancreas, bile
    powder, peptone, casein, dried mares milk, mare
    milk based cosmetics, dried yogurt, mares milk
    oil, mumie powder and liquorices root powder. At
    present Monenzyme R. P. Co. Ltd. is
    establishing small unit for production of rapid
    and ELISA diagnostics of infectious and socially
    related diseases.
  • 4. SHIM Research and Production Co. produces
    nitrogen fertilizer based on Azotobacter

17
Achievements
  • Plant Tissue Culture
  • -Virus free potato planlets using meristem
    culture, virus diagnosis and micropropagation
    techniques have been obtained and transfered to
    farms of the Darkhan Agriculture Research
    Institute.
  • -Micropropogation of some endemic and medicinal
    plants

18
Embryo transfer
  • To increase number of elite groups of goats with
    high quality of cashmere
  • To increase the milk production of dairy cows

19
Vaccines
  • Serum-derived vaccine for HBV
  • Genetically modified strain of Saccharomyces
    cerevisiae , which expresses HBsAg
  • Vaccine against brucellosis and salmonellas

20
Biofertilizers
  • Nitrogen fertilizer based on Azotobacter crococcus

21
Diagnostics
  • HCV
  • HBV
  • AFP
  • Ku fiver
  • Ovine sarcocistosis
  • Oestrosis

22
Cosmetics
  • Green algae
  • Horse milk

23
Food additives
  • Yeast derived protein additives
  • Vitamins, aminoacids

24
Biotechnology Education
  • 6 universities and institutes have biotechnology
    teaching activities
  • Graduate
  • Postgraduate courses
  • Study in foreign countries /by 2003 about 30
    students/
  • Graduate
  • Postgraduate
  • Training
  • Post-doctoral fellowship

25
Constrains
  • Biotechnology capacity building is weak
  • Lack of funds
  • Teaching, research and skills facilities do not
    meet international standards
  • Lack of Biotechnology Industry
  • Best practices from other countries are not
    utilized fully

26
Needs
  • - to develop economic and political
    integrations
  • - to arise all attentions from policy makers,
    scientific, public and international communities
  • - to build and strengthen biotechnology
    capacity
  • - to transfer a new technology
  • - to establish and develop biotechnology
    industry
  • - to improve and expand International
    collaborations

27
Thank you!
Write a Comment
User Comments (0)
About PowerShow.com